SARS-CoV-2IL-32

Lorenzo Miano1, Elena Sinopoli2, Alessandro Cherubini2

  • 1Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy.

Frontiers in immunology
|February 23, 2026
PubMed
概括

在COVID-19大流行期间,以及在患有严重COVID-19的患者中,人体中interleukin-32 (IL-32) 水平增加. 升高的IL-32持续在出院后长达一年,表明长期炎症的可能性.